The most recent Form 13F filing that Jennison Associates L.L.C. made with the S.E.C. reveals that during the third quarter of 2018, the company increased the percentage of its holdings in Inspire Medical Systems, Inc. (NYSE: INSP). The corporation ended up with a total of 172,746 shares of ownership in the company after making purchases of an additional 13,810 shares of the firm’s stock throughout the period. The most recent disclosure that Jennison Associates L.L.C. made with the S.E.C. indicated that the company had a holding in Inspire Medical Systems with a value of approximately $30,640,000. This represented 0.62% of the company’s total ownership.
Institutional investors and hedge funds have bought and sold company shares in recent transactions. These transactions involve the company’s stock. During the second quarter, Royce & Associates L.P. successfully acquired 48.8 percent of Inspire Medical Systems’ shares to bring its total ownership stake to 98.2 percent. Royce & Associates L.P. now holds 30,488 shares of the company’s stock following the acquisition of an additional 10,000 shares during the most recent quarter. The value of Royce & Associates L.P.’s holdings in the company’s stock is currently $5,569,000. During the second quarter, CWM LLC accomplished an overall 231.3% increase in the percentage of ownership it held in Inspire Medical Systems. CWM LLC is now the direct owner of 159 shares of the company’s stock, which have a value of $29,000 when taken together. This represents an increase of 111 shares that were purchased during the most recent quarter of the fiscal year. E.F.G. Asset Management North America Corp. increased the amount of Inspire Medical Systems stock owned by 5.6% during the third quarter of the fiscal year. E.F.G. Asset Management North America Corp. is now the owner of 11,119 shares of the company after making additional purchases of 585 shares during the most recent quarter. The total value of the company’s shares is currently estimated to be $1,975,000. During the second quarter, Driehaus Capital Management L.L.C. made a 3.9% purchase of additional Inspire Medical Systems stock, bringing the total amount of the company’s holdings to 98.1%. Driehaus Capital Management L.L.C. now holds 327,799 shares of the company’s stock, valued at $59,879,000, following the acquisition of an additional 12,412 shares during the most recent quarter. Driehaus Capital Management L.L.C purchased these shares.
Last but not least, during the second quarter, Landscape Capital Management L.L.C. increased the percentage of Inspire Medical Systems, which has a stake, by 3.2%. This certainly should not be considered the least important development. After purchasing 380 shares during the most recent quarter, Landscape Capital Management L.L.C. now directly owns 12,343 shares of the company’s stock, which has a market value of $2,255,000. The shares were purchased during the most recent quarter. The vast majority of the company’s shares, or 97.04%, are held in institutional investors’ portfolios.
The first transaction involving shares of INSP took place on Tuesday for $256.93 per share. At the moment, Inspire Medical Systems, Inc. is trading at a 52-week low of $142.74, while the company is currently trading at a 52-week high of $272.04. The stock’s 50-day moving average is currently at $238.13, while its 200-day moving average is at $210.50. Both of these moving averages are above their respective 200-day moving averages.
Inspire Medical Systems (NYSE: INSP) made the announcement regarding the outcomes of its earnings report for the third quarter on November 1, a Tuesday. The company reported earnings per share (EPS) of $0.60 for the quarter, which was $0.15 higher than the consensus estimate of $0.75 for the quarter. Earnings per share (EPS) for the quarter came in at $0.60, which was $0.15 better than the consensus estimate of $0.75. Several analysts had made the estimate. Inspire Medical Systems’ net margin and return on equity were negative, coming in at -14.47% and -17.52%, respectively. Neither of these metrics was profitable for the company. According to projections made by market analysts, revenue for the company’s most recent fiscal quarter was expected to fall somewhere in the range of $95.62 million to $109.19 million. Experts in market research anticipated that Inspire Medical Systems, Inc. would incur a loss of $2.41 for each share traded during the current financial year.
In addition, on November 11, Jerry C. Griffin, Director of Inspire Medical Systems, sold 9,217 shares of the company’s stock. It costs 2,040,828.14 dollars to purchase the shares, an average price of $221.42 per share. After the completion of the transaction, the director is now the direct owner of 2,060 shares of the company’s stock. The total value of these shares is $456,125.20. If you follow the link, which will take you to a legal file submitted to the S.E.C., you will have the opportunity to acquire additional information regarding the transaction. According to the article in the news source, on December 16, Director Marilyn C. Nelson sold 25,211 shares of the company’s stock. The news source reported this transaction. The stock sale resulted in total revenue of $6,170,896.47, with each share’s average price being $244.77. Th